CCDC99 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.668000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.533600E-01
Normal-vs-Stage2
9.387200E-01
Normal-vs-Stage3
1.210630E-01
Normal-vs-Stage4
9.748800E-01
Stage1-vs-Stage2
8.298400E-01
Stage1-vs-Stage3
2.055600E-01
Stage1-vs-Stage4
8.707000E-01
Stage2-vs-Stage3
7.267600E-02
Stage2-vs-Stage4
9.650600E-01
Stage3-vs-Stage4
1.524190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.951400E-01
Normal-vs-AfricanAmerican
8.442800E-01
Normal-vs-Asian
6.544200E-01
Caucasian-vs-AfricanAmerican
9.117800E-01
Caucasian-vs-Asian
5.253000E-01
AfricanAmerican-vs-Asian
7.514000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.053000E-01
Normal-vs-Female
9.706200E-01
Male-vs-Female
3.965200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.825600E-01
Normal-vs-Age(41-60Yrs)
7.675400E-01
Normal-vs-Age(61-80Yrs)
6.741800E-01
Normal-vs-Age(81-100Yrs)
9.116000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.875610E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.472200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.535010E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.182210E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.874600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.546200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.578800E-01
Normal-vs-Daily Drinker
6.011800E-01
Normal-vs-Weekly Drinker
9.677400E-01
Normal-vs-Occasional Drinker
9.743200E-01
Normal-vs-Social Drinker
8.861400E-01
Non Drinker-vs-Daily Drinker
8.967800E-01
Non Drinker-vs-Weekly Drinker
3.576400E-01
Non Drinker-vs-Occasional Drinker
3.259400E-01
Non Drinker-vs-Social Drinker
3.361000E-01
Daily Drinker-vs-Weekly Drinker
4.415000E-01
Daily Drinker-vs-Occasional Drinker
4.158200E-01
Daily Drinker-vs-Social Drinker
4.149000E-01
Weekly Drinker-vs-Occasional Drinker
9.900000E-01
Weekly Drinker-vs-Social Drinker
9.174000E-01
Occasional Drinker-vs-Social Drinker
9.056000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.060200E-01
Normal-vs-Grade 2
9.306200E-01
Normal-vs-Grade 3
9.750000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.780700E-03
Grade 1-vs-Grade 3
4.000800E-03
Grade 1-vs-Grade 4
8.060200E-01
Grade 2-vs-Grade 3
3.238400E-01
Grade 2-vs-Grade 4
9.306200E-01
Grade 3-vs-Grade 4
9.750000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.181600E-01
Normal-vs-NonDiabetic
8.074000E-01
Diabetic-vs-NonDiabetic
2.314800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.036800E-01
Normal-vs-NoPancreatitis
7.735800E-01
Pancreatitis-vs-NoPancreatitis
3.766400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.665400E-01
Normal-vs-N1
9.286600E-01
N0-vs-N1
5.211800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.231600E-01
Normal-vs-TP53-NonMutant
7.213200E-01
TP53-Mutant-vs-TP53-NonMutant
8.203700E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
